Susanne Schnittger

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

A copy number repeat polymorphism in the transactivation domain of the CEPBA gene is possibly associated with a protective effect against acquired CEBPA mutations: an analysis in 1135 patients with AML and 187 healthy controls.

A copy number repeat polymorphism in the transactivation domain of the CEPBA gene is possibly associated with a protective effect against acquired CEBPA mutations: an analysis in 1135 patients with AML and 187 healthy controls.

Journal: Experimental hematology
Published: July 10, 2010

Associations between imatinib resistance conferring mutations and Philadelphia positive clonal cytogenetic evolution in CML.

Associations between imatinib resistance conferring mutations and Philadelphia positive clonal cytogenetic evolution in CML.

Journal: Genes, chromosomes & cancer
Published: July 08, 2010

RQ-PCR based WT1 expression in comparison to BCR-ABL quantification can predict Philadelphia negative clonal evolution in patients with imatinib-treated chronic myeloid leukaemia.

RQ-PCR based WT1 expression in comparison to BCR-ABL quantification can predict Philadelphia negative clonal evolution in patients with imatinib-treated chronic myeloid leukaemia.

Journal: British journal of haematology
Published: July 24, 2009

Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML.

Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML.

Journal: Blood
Published: July 10, 2009

Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera.

Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera.

Journal: Haematologica
Published: March 03, 2009

Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients.

Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients.

Journal: Leukemia
Published: February 09, 2007

D324N single-nucleotide polymorphism in the FLT3 gene is associated with higher risk of myeloid leukemias.

D324N single-nucleotide polymorphism in the FLT3 gene is associated with higher risk of myeloid leukemias.

Journal: Genes, chromosomes & cancer
Published: December 02, 2005

KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival.

KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival.

Journal: Blood
Published: October 29, 2005
Showing 1-8 of 8

Last Updated: 09/26/2026